Dr. Pankaj Khandelwal, MD
What this data tells you about Dr. Khandelwal
Dr. Pankaj Khandelwal is a medical oncology in Odessa, TX, with 19 years in practice. Based on federal Medicare data, Dr. Khandelwal performed 94,639 Medicare services across 2,996 unique beneficiaries.
Between the years covered by Open Payments, Dr. Khandelwal received a total of $83 from 3 pharmaceutical and/or device companies across 3 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khandelwal is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) | 24,000 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 14,600 | $40 | $136 |
| Anti-nausea injection (fosaprepitant) | 13,500 | $0 | $5 |
| Contrast dye for imaging (iodine-based) | 11,171 | $0 | $3 |
| Darbepoetin injection (Aranesp) for anemia | 8,945 | $2 | $20 |
| Paclitaxel chemotherapy injection | 8,475 | $0 | $8 |
| Dexamethasone injection (steroid) | 3,100 | $0 | $1 |
| Injection, granisetron hydrochloride, 100 mcg | 1,700 | $0 | $24 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,330 | $1 | $114 |
| Blood draw (venipuncture) | 734 | $8 | $20 |
| Complete blood count (CBC) with differential | 676 | $8 | $36 |
| Comprehensive metabolic blood panel | 507 | $10 | $64 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 496 | $21 | $157 |
| Administration of chemotherapy into vein, 1 hour or less | 417 | $95 | $707 |
| Injection, magnesium sulfate, per 500 mg | 406 | $1 | $6 |
| Office visit, established patient (30-39 min) | 336 | $88 | $368 |
| Injection, carboplatin, 50 mg | 299 | $2 | $300 |
| Administration of chemotherapy into vein, each additional hour | 264 | $21 | $161 |
| Injection, fluorouracil, 500 mg | 229 | $2 | $13 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 193 | $133 | $3,675 |
| Injection, zoledronic acid, 1 mg | 189 | $6 | $431 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 180 | $46 | $313 |
| Injection of additional new drug or substance into vein | 171 | $11 | $108 |
| Magnesium level test | 167 | $7 | $29 |
| Infusion into a vein for hydration, each additional hour | 167 | $9 | $75 |
| Office visit, established patient, complex (40-54 min) | 163 | $129 | $496 |
| Administration of additional new drug or substance into vein, 1 hour or less | 144 | $47 | $344 |
| Injection, diphenhydramine hcl, up to 50 mg | 139 | $1 | $7 |
| Drug injection, under skin or into muscle | 134 | $11 | $96 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 111 | $14 | $100 |
| Ct scan of chest with contrast | 109 | $42 | $821 |
| CT scan of abdomen and pelvis with contrast | 103 | $159 | $1,067 |
| Lactate dehydrogenase (enzyme) level | 103 | $6 | $31 |
| Reticulated (young) platelet measurement | 103 | $35 | $143 |
| Infusion, normal saline solution , 1000 cc | 103 | $2 | $19 |
| Irrigation of implanted venous access drug delivery device | 95 | $17 | $114 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 92 | $20 | $128 |
| Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | 88 | $75 | $70 |
| Unclassified drugs | 85 | $1 | $8 |
| Basic metabolic blood panel | 79 | $8 | $49 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 72 | $25 | $145 |
| CT scan of chest, without contrast | 69 | $31 | $686 |
| Ct scan of abdomen and pelvis without contrast | 59 | $72 | $560 |
| Microscopic examination for white blood cells with manual cell count | 51 | $4 | $22 |
| Complete blood count (CBC), automated | 51 | $6 | $34 |
| PSA test (prostate cancer screening) | 49 | $18 | $94 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 47 | $1 | $19 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 43 | $4 | $25 |
| Infusion into a vein for hydration, 31-60 minutes | 38 | $24 | $256 |
| Ferritin level test (iron stores) | 37 | $13 | $60 |
| Iron level test | 37 | $6 | $27 |
| Iron binding capacity test | 37 | $9 | $35 |
| Administration of additional new drug or substance into vein using push technique | 33 | $38 | $289 |
| Office visit, established patient (20-29 min) | 30 | $58 | $250 |
| Carcinoembryonic antigen (cea) protein level | 23 | $19 | $99 |
| New patient office visit (45-59 min) | 23 | $121 | $565 |
| Injection of drug or substance into vein | 21 | $27 | $247 |
| Ct scan of soft tissue of neck with contrast | 16 | $60 | $658 |
Industry Payment Transparency
Open Payments through 2021 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2021)
Associated products mentioned in payments ›
The majority of payments (100%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in medical oncology and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2021 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Khandelwal is a mixed practice specialist, with above-average Medicare volume (top 11% in TX), and speaking/promotional industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Khandelwal experienced with iron sucrose injection (venofer)?
Does Dr. Khandelwal receive payments from pharmaceutical companies?
How do Dr. Khandelwal's costs compare to other medical oncologys in Odessa?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology